scholarly journals The Soy Isoflavones for Reducing Bone Loss (SIRBL) Study: a 3-y randomized controlled trial in postmenopausal women

2009 ◽  
Vol 91 (1) ◽  
pp. 218-230 ◽  
Author(s):  
D Lee Alekel ◽  
Marta D Van Loan ◽  
Kenneth J Koehler ◽  
Laura N Hanson ◽  
Jeanne W Stewart ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Bone Loss ◽  
Postmenopausal Women ◽  
Controlled Trial ◽  
Soy Isoflavones ◽  
Randomized Controlled

One-year psoas training can prevent lumbar bone loss in postmenopausal women: A randomized controlled trial

1993 ◽  
Vol 53 (5) ◽  
pp. 307-311 ◽  
Author(s):  
M. Revel ◽  
M. A. Mayoux-Benhamou ◽  
J. P. Rabourdin ◽  
F. Bagheri ◽  
C. Roux
Keyword(s):  
Randomized Controlled Trial ◽  
Bone Loss ◽  
Postmenopausal Women ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
One Year

A Calcium-Collagen Chelate Dietary Supplement Attenuates Bone Loss in Postmenopausal Women with Osteopenia: A Randomized Controlled Trial

2015 ◽  
Vol 18 (3) ◽  
pp. 324-331 ◽  
Author(s):  
Marcus L. Elam ◽  
Sarah A. Johnson ◽  
Shirin Hooshmand ◽  
Rafaela G. Feresin ◽  
Mark E. Payton ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Bone Loss ◽  
Postmenopausal Women ◽  
Dietary Supplement ◽  
Controlled Trial ◽  
Randomized Controlled

Comparative Effects of Oestrogen and a Progestogen on Bone Loss in Postmenopausal Women

1978 ◽  
Vol 54 (2) ◽  
pp. 193-195 ◽  
Author(s):  
R. Lindsay ◽  
D. M. Hart ◽  
D. Purdie ◽  
M. M. Ferguson ◽  
A. S. Clark ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Bone Loss ◽  
Bone Formation ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Controlled Trial ◽  
Urinary Output ◽  
Photon Absorptiometry ◽  
Randomized Controlled ◽  
Mineral Loss

1. The value of progestogen therapy in the prevention of postmenopausal bone loss was assessed in 30 women, by a preliminary randomized controlled trial of gestronol or mestranol, in comparison with a placebo. 2. When the skeletal response was measured by photon absorptiometry, bone mineral loss was prevented by both the oestrogen and the progestogen. 3. We confirm that mestranol significantly reduced the urinary output of hydroxyproline-containing peptide, but this did not occur during gestronol therapy, suggesting that progestogen has a different action on bone, perhaps stimulating bone formation.

Sign in / Sign up

Export Citation Format

Share Document